Clinical Trial Update: Response-based Treatment of High-risk Neuroblastoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Samsung Medical Center evaluating response-based treatment for newly diagnosed high-risk neuroblastoma; current status is not repo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Samsung Medical Center | Conditions: Newly Diagnosed High Risk Neuroblastoma | Phase 2 | Status: UNKNOWN